Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.47 |
| ▸ | GLS | O94925 | 1/20 | 0.46 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19668491 | 1.00 | CYP3A4 (0.47) | CYP3A4CYP3A5GLSGPR119MEN1 | |
| SCHEMBL1852622 | 0.86 | GLS (0.57) | CYP3A4CYP3A5GLSGPR119MEN1 | |
| SCHEMBL5183732 | 0.85 | MEN1 (0.49) | CYP3A4CYP3A5GLSGPR119MEN1 | |
| SCHEMBL5184046 | 0.85 | ALDH1A1 (0.46) | CYP3A4CYP3A5GLSMEN1KMT2A | |
| SCHEMBL4883412 | 0.82 | CYP3A4 (0.52) | CYP3A4CYP3A5GLSGPR119MEN1 | |
| SCHEMBL13476475 | 0.81 | P2RX3 (0.48) | GLSGPR119ATMLMNANPC1 | |
| SCHEMBL14128435 | 0.79 | GPR119 (0.50) | CYP3A4CYP3A5GLSGPR119MEN1 | |
| SCHEMBL19668532 | 0.79 | CFTR (0.46) | CYP3A4CYP3A5GLSNPC1ALDH1A1 | |
| SCHEMBL19668681 | 0.79 | CYP3A4 (0.59) | CYP3A4CYP3A5GLSGPR119 | |
| SCHEMBL29363322 | 0.79 | CYP3A4 (0.59) | CYP3A4CYP3A5GLSGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119731211-A | Cross-linked multispecific antibodies | 恩拉扎治疗公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119136842-A | Cyclodextrin complexes that specialize in resolution mediators | 西蒂斯制药有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118922209-A | Cross-linked antibodies | 恩拉扎治疗公司 | 2024-11-08 | — | — | CN | disclosed |
| WO-2024229281-A1 | ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOF | CITY OF HOPE (US) | 2024-11-07 | — | — | WO | disclosed |
| EP-4452333-A1 | CROSSLINKING ANTIBODIES | Enlaza Therapeutics, Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| CN-111902394-B | Compositions and methods relating to salts of specific pro-inflammatory regressive mediators | 西蒂斯制药有限责任公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-4301767-A1 | BIOREACTIVE COMPOUNDS AND METHODS OF USE THEREOF | The Regents of the University of California (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-117098768-A | Biologically reactive compounds and methods of use thereof | 加利福尼亚大学董事会 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023122753-A1 | CROSSLINKING ANTIBODIES | ENLAZA THERAPEUTICS, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| EP-4200444-A1 | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES | Singular Genomics Systems, Inc. (US) | 2023-06-28 | — | — | EP | disclosed |
| EP-4117640-A1 | FEM1B PROTEIN BINDING AGENTS AND USES THEREOF | The Regents of the University of California (US) | 2023-01-18 | — | — | EP | disclosed |
| WO-2022241041-A2 | ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOF | CITY OF HOPE (US) | 2022-11-17 | — | — | WO | disclosed |
| WO-2022236176-A2 | FXA PROTEIN FOR TREATING AND/OR PREVENTING COVID-19 | CITY OF HOPE (US) | 2022-11-10 | — | — | WO | disclosed |
| CN-109562186-B | Compositions and methods relating to salts of specialized proresolving mediators | 西蒂斯制药有限责任公司 | 2022-09-13 | — | — | CN | disclosed |
| WO-2022187273-A1 | BIOREACTIVE COMPOUNDS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-09-09 | — | — | WO | disclosed |
| WO-2022094415-A1 | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES | Singular Genomics Systems, Inc. (US) | 2022-05-05 | — | — | WO | disclosed |
| WO-2022076369-A1 | A FACTOR H BINDING PROTEIN B (FHBB) BASED CHIMERIC VACCINE FOR THE PREVENTION AND TREATMENT OF PERIODONTAL DISEASE | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2022-04-14 | — | — | WO | disclosed |